Press release
Peptide Based Hematological Disorders Therapeutics Industry Outlook and Market Development Analysis Reveals Forecast for the Period 2017-2022
Fact.MR
Get A Free Sample Copy of Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=189
North America Market Set to Dominate the Global Peptide Based Hematological Disorders Therapeutics Market in Terms of Revenue
The market in North America is set to dominate the global peptide based hematological disorders therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America peptide based hematological disorders therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.
Icatibant Segment Poised to Touch a Value of Nearly US$ 410 Mn in 2022
As per the forecast of Fact.MR, the icatibant segment is expected to reach a value of nearly US$ 410 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Icatibant segment is expected to account for more than three-fourth of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.
Hospital Pharmacies Segment to exhibit a CAGR of 7.4% During the Assessment Period
As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 260 Mn in the year 2022. This represents a CAGR of 7.4% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of global peptide based hematological disorders therapeutics market through 2022, which includes Shire plc.
Browse Full Report with TOC@ https://www.factmr.com/report/189/peptide-based-hematological-disorders-therapeutics-market
Table of Contents:
Global Peptide Based Hematological Disorders Therapeutics Market – Executive Summary
Global Peptide Based Hematological Disorders Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Hematological Disorders Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Hematological Disorders Therapeutics Market Definition
2.2. Global Peptide Based Hematological Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Hematological Disorders Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Hematological Disorders Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Icatibant Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
Continued………..
Check Discount on this Report@ https://www.factmr.com/connectus/sample?flag=D&rep_id=189
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Hematological Disorders Therapeutics Industry Outlook and Market Development Analysis Reveals Forecast for the Period 2017-2022 here
News-ID: 1035562 • Views: …
More Releases from Fact.MR
Silicon Anode Slurries Market Forecast 2026-2036: Market Size, Share, Competitiv …
The global silicon anode slurries market is set for significant expansion between 2026 and 2036, fueled by the rising adoption of high-energy-density lithium-ion batteries across electric vehicles (EVs), consumer electronics, and grid-scale energy storage. As battery manufacturers increasingly transition from graphite to silicon-enhanced anodes, the demand for high-performance, scalable silicon anode slurries is projected to grow sharply.
To access the complete data tables and in-depth insights, request a Discount On The…
Silicon Anode Slurries Market Forecast 2026-2036: Market Size, Share, Competitiv …
The global silicon anode slurries market is set for significant expansion between 2026 and 2036, fueled by the rising adoption of high-energy-density lithium-ion batteries across electric vehicles (EVs), consumer electronics, and grid-scale energy storage. As battery manufacturers increasingly transition from graphite to silicon-enhanced anodes, the demand for high-performance, scalable silicon anode slurries is projected to grow sharply.
To access the complete data tables and in-depth insights, request a Discount On The…
Low-Siloxane Cleanroom Wall Coatings Market Deep-Dive 2026-2036: Strategic Forec …
The low-siloxane cleanroom wall coatings market is poised for steady growth over the next decade, driven by rising contamination-control requirements across semiconductor, pharmaceutical, biotechnology, and precision manufacturing industries. These coatings are specifically engineered to minimize siloxane outgassing and volatile organic compound emissions, helping maintain ultra-clean environments where even trace contamination can disrupt production quality.
By 2036, the market for low-siloxane cleanroom wall coatings is expected to grow to USD 91.04 million.…
Low-Siloxane Cleanroom Wall Coatings Market Deep-Dive 2026-2036: Strategic Forec …
The low-siloxane cleanroom wall coatings market is poised for steady growth over the next decade, driven by rising contamination-control requirements across semiconductor, pharmaceutical, biotechnology, and precision manufacturing industries. These coatings are specifically engineered to minimize siloxane outgassing and volatile organic compound emissions, helping maintain ultra-clean environments where even trace contamination can disrupt production quality.
By 2036, the market for low-siloxane cleanroom wall coatings is expected to grow to USD 91.04 million.…
More Releases for Peptide
ShiLai Peptide to Invest $32 Million in State-of-the-Art Peptide Laboratory in H …
ShiLai Peptide's CEO, Luo Binhua, said the investment reflects the company's commitment to a "new science model" that integrates research-driven development, controlled production, and specialized customer support.
ShiLai Peptide [https://retatrutidesupplier.com/], a leading provider of high-purity, customizable research peptides, announced plans to invest $32 million to build a state-of-the-art peptide research and production laboratory in Hangzhou. The facility is designed to meet world-class GMP standards, aiming to strengthen ShiLai's global supply of…
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
